D. J. Betteridge

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington et al. · The Lancet · 2004 · 3.8K citations

Metabolic Syndrome, Primary Prevention, Diabetes Management +8

Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke

Robert Wilcox, Marie‐Germaine Bousser, D. J. Betteridge et al. · Stroke · 2007 · 473 citations

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome

Gerard S. Conway, Rajendra Agrawal, D. J. Betteridge et al. · Clinical Endocrinology · 1992 · 426 citations

Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels

Peter Clarkson, David S. Celermajer, Ann E. Donald et al. · Journal of the American College of Cardiology · 1996 · 420 citations

Metabolic Syndrome, Disease Duration, Cardiovascular Disease +12

Plasma 8‐epi‐PGF_2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus

N.K. Gopaul, Erik Änggård, Anthony I. Mallet et al. · FEBS Letters · 1995 · 390 citations

Lipid Peroxidation, Pathology, Plasma 8‐Epi‐pgf +18